Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

August 30, 2025

Study Completion Date

August 31, 2025

Conditions
Subjective Cognitive ConcernsMild Cognitive ImpairmentMild Behavioral ImpairmentHealthy Aging
Interventions
DEVICE

AROMHA Brain Health Test

The AROMHA Brain Health Test is a self-administered, at-home smell test developed as a potential primary screen for identifying individuals at risk for developing Alzheimer's and as a means to follow disease progression in individuals without overt cognitive symptoms. The smell test device consists of five physical smell cards and a paired web-based app that directs participants on how to sample odors and asks them questions regarding what they have smelled. The 45-minute smell test battery includes measures of odor intensity, identification, memory, and discrimination.

Trial Locations (1)

02129

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER